We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleAR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas.AuthorsBush ML; Oblinger J; Brendel V; Santarelli G; Huang J; Akhmametyeva EM; Burns SS; Wheeler J; Davis J; Yates CW; Chaudhury AR; Kulp S; Chen CS; Chang LS; Welling DB; Jacob APublicationNeuro-oncology, 2011, Vol 13, Issue 9, p983ISSN1523-5866Publication typearticleDOI10.1093/neuonc/nor072